Edmond McNack is a 40-year-old former Jackson County sheriff's deputy. On March 25, 1998, McNack was transferring a prisoner to a hospital when she bit him on the finger. McNack sought emergency treatment at the hospital. The emergency room doctor prescribed a combination AZT/CT3 prophylaxis, hereinafter "HAART" (highly active anti-retroviral therapy), in case the prisoner was HIV positive. Both the prisoner and McNack were later tested HIV negative.
During the course of the 10-week HAART administration, McNack developed a number of symptoms. McNack began to feel nauseated and tired. McNack had a fever, night sweats, and blurry vision within one to two weeks of taking the medications. McNack began to lose weight. McNack ultimately terminated the course of HAART prophylaxis two weeks early.
McNack continued to suffer many symptoms. McNack required numerous hospitalizations and was seen by
many doctors during this time. By September 1998 McNack was diagnosed with sarcoidosis. McNack's sarcoid condition was treated with high-dose prednisone. McNack developed avascular necrosis of both hips as a side effect of the prednisone. McNack received bilateral hip replacements.
McNack has had his gallbladder removed as well. McNack has many symptoms and complaints related to the sarcoidosis and accompanying treatment. McNack complains of fatigue, joint pain, hip pain, tremors, wrist pain, loss of balance, and numbness. McNack has not worked since September 2000 when his employment with the county was terminated.
McNack claims he developed or aggravated an unknown preexisting sarcoid condition as a result of taking the HAART prophylaxis.
There is no dispute that McNack sustained a human bite and was administered HAART prophylaxis. There is no dispute that McNack suffers from sarcoidosis. The question is whether the administration of the HAART prophylaxis either caused or aggravated McNack's sarcoidosis.
It is the burden of the claimant to establish the causal connection between the accident and resulting injury. Landers v. Chrysler Corp., 963 S.W.2d 275, 279 (Mo.App. E.D. 1997). In this case the issue is one of medical causation, which must be established by expert opinion. The medical causation must be demonstrated by "scientific or medical evidence showing the cause and effect relationship between the complained of condition and the asserted cause." Landers at 279; McGrath v. Satellite Sprinkler Systems, 877 S.W.2d 704, 708 (Mo.App. 1994). Additionally, medical expert opinion must be based on reasonable medical certainty that a condition was caused by a particular event or circumstance. Carter v. Jones Truck Lines, Inc., 943 S.W.2d 821 (Mo.App. S.D. 1997).
Expert testimony expressed in terms of "might" or "could" without additional evidence of causation is insufficient to support a specific finding. Carter at 826; Wiedmaier v. Robert McNeil Corp., 718 S.W.2d 174 (Mo.App. W.D. 1986); Shackelford v. West Central Electric Cooperative, Inc., 674 S.W.2d 58, 62 (Mo.App. W.D. 1984).
The parties have each provided expert opinions as to the medical causation issue presented in this claim. Dr. Edward Friedlander is a medical instructor and board-certified pathologist. Friedlander has many years of experience in pathology and has testified as to causation issues in both criminal and civil matters. Dr. Yasmine Wasfi is an instructor with National Jewish Hospital in Denver, Colorado. Dr. Wasfi specializes in treatment and research of sarcoidosis. She has treated over 100 patients with sarcoidosis.
Both Dr. Friedlander, on behalf of McNack, and Dr. Wasfi, on behalf of the employer, agree that McNack has sarcoidosis but disagree as to whether the HAART regimen taken by McNack caused him to develop sarcoidosis or otherwise made preexisting dormant sarcoidosis symptomatic. Between March 25, 1998, and June 10, 1998, McNack had a drop in his albumin level from 4 to 3. Dr. Friedlander opines this is indicative of sarcoid symptomology. Dr. Wasfi disagrees. Dr. Wasfi testified that chest x-rays of June 10, 1998, revealed evidence of sarcoidosis. Both doctors agree that there is no evidence indicating McNack had sarcoidosis or its symptoms prior to March 25, 1998.
Dr. Friedlander testified that although not a certainty, he thought the taking of the HAART probably caused McNack to develop sarcoidosis or otherwise made a preexisting dormant sarcoidosis symptomatic for the following reasons: (1) the temporal relationship between the taking of the HAART the development of the sarcoidosis indicated on the chest x-ray of June 10, 1998, and the drop in McNack's albumin level was too strong to be coincidental; (2) HIV positive patients have developed sarcoidosi